GlassScriptPhysician profile
Ibrahim B Cetindag
NPI 1447471396
$11,972.54
in general payments reported to CMS, 2019-2025
23 companies · $2,416 in 2025
The $2,416 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $3,049 · 2021: $84.80 · 2022: $407 · 2023: $3,616 · 2024: $1,929 · 2025: $2,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,485 · Food and Beverage: $3,433 · Gift: $43.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,484.72 |
| Food and Beverage | $3,432.94 |
| Gift | $43.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,644.53 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $2,859.53 | 2019-2025 | Phasix Mesh |
| Nuvasive, INC. | $2,135.86 | 2023 | Alif |
| Medtronic, INC. | $332.57 | 2022-2023 | |
| Ethicon US, LLC | $267.49 | 2024 | Echelon; Endopath, Echelon Endopath, Endopath |
| Becton, Dickinson and Company | $168.40 | 2023 | Phasix Mesh |
| Conmed Corporation | $139.80 | 2022-2023 | Conmed Specimen Retrieval, Visiclear, Airseal |
| Kerecis Limited | $73.05 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Allergan, INC. | $60.82 | 2019 | |
| Novo Nordisk INC | $49.07 | 2021-2023 | Wegovy |
| Organogenesis INC. | $44.39 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.67 | 2019 | |
| Innocoll Pharmaceuticals Limited | $19.70 | 2021 | |
| Ironwood Pharmaceuticals, INC | $19.69 | 2021 | |
| Baxter Healthcare | $17.49 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $17.21 | 2022 | |
| Medela LLC | $15.65 | 2020 | |
| Abbvie INC. | $14.34 | 2019 | |
| Shire North American Group INC | $13.38 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.39 | 2020 | |
| Olympus America INC. | $12.18 | 2021 | |
| Covidien LP | $12.12 | 2019 | |
| Convatec INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Cetindag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.